NLRP3 plays an important role in the progression of metabolic disorders, including obesity-induced insulin resistance and the development and severity of gout, nonalcoholic fatty liver disease, and type 2 diabetes [4]. Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.